FindTrial
Sign In

The role of GDNF in cancer induced pain and depression

The role of glial cell line derived neurotrophic factor in cancer induced pain and depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016935
Enrollment
Unknown
Registered
2018-07-04
Start date
2018-08-03
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain and depression

Interventions

cancer pain group:none
no cancer pain group:none

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of malignant tumor patients and/or diagnosis of bone metastasis by whole-body bone scan (40-70 years old); 2. Duration of cancer pain = 3 months; 3. Pain score = 4 points.

Exclusion criteria

Exclusion criteria: 1. with severe heart and lung disease, severe liver and kidney dysfunction, severe anemia and nervous system diseases; 2. depression before the onset of cancer pain.

Design outcomes

Primary

MeasureTime frame
GDNF;—

Countries

China

Contacts

Public ContactSong Zongbin

Xiangya Hospital of Central South University

songzb2001@163.com+86 13787246060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026